Aripiprazole Tablet
Product Images NDC 46708-259

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 46708-259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg 30's Hdpe Bottle Pack (Aripiprazole 10mg)

10 mg 30's Hdpe Bottle Pack (Aripiprazole 10mg)
Each tablet contains 10 mg of aripiprazole USP, which is used for the treatment of schizophrenia and bipolar disorder. The tablets are dispensed by the pharmacist with the help of the accompanying package insert for indications and dosage information. The tablets should be stored between 20° to 25°C (68° to 77°F), with excursions permitted to 15-30°C (59-86°F). The medication is manufactured by Alembic Pharmaceuticals Limited in India. This text provides necessary details about the aripiprazole tablets, including the batch and expiry details.*
FDA Label Image

15 mg 30's Hdpe Bottle Pack (Aripiprazole 15mg)

15 mg 30's Hdpe Bottle Pack (Aripiprazole 15mg)
Each tablet contains 15 mg of aripiprazole USP used for certain mental/mood disorders. Store at room temperature and follow dosage instructions provided in the package insert. Made by Alembic Pharmaceuticals Limited in India. Not available: specific indications for use or side-effect information.*
FDA Label Image

20 mg 30's Hdpe Bottle Pack (Aripiprazole 20mg)

20 mg 30's Hdpe Bottle Pack (Aripiprazole 20mg)
This is a medication called Aripiprazole, manufactured by Ambic Pharmaceuticals limited. The tablets contain 20 mg of Aripiprazole USP, used for certain indications. The packaging includes dosage instructions, medication guide, and batch details. Expiry is mentioned as well.*
FDA Label Image

2 mg 30's Hdpe Bottle Pack (Aripiprazole 2mg)

2 mg 30's Hdpe Bottle Pack (Aripiprazole 2mg)
Aripiprazole tablets contain 2 mg of arpiprazole USP and are available in packs of 30 tablets. Pharmacists are advised to refer to the package insert for dosage and indication information. The tablets should be stored within the temperature range of 20 to 25°C (68 to 77°F) with excursions tolerated to 15-30°C (59-86°F). The manufacturer is Alembic Pharmaceuticals Limited located in Gujarat, India. This medication is available by prescription only.*
FDA Label Image

30 mg 30's Hdpe Bottle Pack (Aripiprazole 30mg)

30 mg 30's Hdpe Bottle Pack (Aripiprazole 30mg)
Each tablet contains 30 mg of arpiprazole used for treatment of certain mental/mood disorders such as bipolar disorder, schizophrenia, and Tourette's disorder. Dosage and indication information can be found in the package insert. The tablets must be stored at a controlled room temperature of 20° to 25°C (68° to 77°F) with excursions permitted to 15-30°C (59-86°F). The product is manufactured in India by Alembic Pharmaceuticals Limited as a prescription-only medication. The text includes manufacturing license number, NDC code, medication guide instruction, number of tablets, and batch information including expiry date.*
FDA Label Image

Figure 3 (Aripiprazole 3figure)

FDA Label Image

5 mg 30's Hdpe Bottle Pack (Aripiprazole 5mg)

FDA Label Image

Figure 2 (Aripiprazole Figure2)

Figure 2 (Aripiprazole Figure2)
The text appears to be a table or chart displaying the effects of various drugs on aripiprazole. It includes information such as whether the drug is an inducer or inhibitor of certain enzymes, as well as the percentage change relative to a reference without the interacting drug. Without further context or clearer text, it is difficult to provide more specific information.*
FDA Label Image

Figure 4 (Aripiprazole Figure4)

Figure 4 (Aripiprazole Figure4)
The text seems to be a table or a figure with various headings and data points related to special populations. Not available.*
FDA Label Image

Figure 5 (Aripiprazole Figure5)

FDA Label Image

Figure 6 (Aripiprazole Figure6)

Figure 6 (Aripiprazole Figure6)
This appears to be a graph showing the "Proportion with Relapse" for a drug called "Arpiprazole" versus a placebo. The graph also provides numbers for the "Number of Subjects at Risk" on the x-axis and "Days from Randomization" on the y-axis. However, without additional context or a clear title, it is difficult to determine more specific information about the purpose or results of the graph.*
FDA Label Image

Structure (Aripiprazole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.